(see Antiulcer Agents)
| Drug and Dosage | Use | Action | Assessment: Side Effects |
|---|---|---|---|
| Antiadrenal Agent | |||
| Aminoglutethimide (Cytadren)—PO 250 mg q6h | Cushing’s syndrome | Inhibits enzymatic conversion of cholesterol to pregnenolone, thus reducing synthesis of adrenal glucocorticoids/mineralocorticoids | Cortical hypofunction, hypotension, hypothyroidism |
| NURSING IMPLICATIONS: Monitor: vital signs, laboratory values, disease signs and symptoms; observe frequently during periods of stress | |||